Faustian Bargain

In his Opinion article, T.V. Rajan has written a thoughtful and accurate portrayal of what has happened to too many biomedical researchers in recent years. I agree with virtually everything he says. I am a college professor who teaches and does modest research with undergraduates. After a quarter-century, I still love science and show it, still do my own research, and still spend hours in the library reading papers to try to keep up. When my students go off in the summers to do research a

Written byDavid Sadava
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In his Opinion article, T.V. Rajan has written a thoughtful and accurate portrayal of what has happened to too many biomedical researchers in recent years. I agree with virtually everything he says.

I am a college professor who teaches and does modest research with undergraduates. After a quarter-century, I still love science and show it, still do my own research, and still spend hours in the library reading papers to try to keep up. When my students go off in the summers to do research at large centers, they find team leaders and entrepreneurs, not scientists. And they come back to my classroom confused. Doesn't a scientist do science? they ask. Don't scientists like science? Is this a life to which my students should aspire?

Too many faculty colleagues of mine at research-intensive institutions spend all day in their offices writing grants to "lay more bricks." They certainly don't seem ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies